Being seen by a physician that is both an expert in a specific condition and getting an "in person" second opinion from that physician are often essential to receiving the best care.

Because Myeloproliferative Neoplasms (MPN) are uncommon and  treatment is evolving it is important to find physicians who have experience and are focused on improving treatment. In the United States there are physicians dedicated to advancing the treatment of Polycythemia, Myelofibrosis, and Essential Thrombocythemia. Patients should at least consider getting an “in person” second opinion by one of these experts. 

The physicians listed below all have expertise in managing MPN's and are the ones most likely to be performing clinical trials which are an important component of moving MPN treatment forward. Click here to learn more about second opinions.

Arkansas

  • Kamal Patel MD – Carti Cancer Center

Arizona

California

Connecticut

  • Nikolai Podoltsev MD – Yale Cancer Center

Colorado

Florida

Georgia

Illinois

Indiana

  • Larry Cripe MD Indiana University
  • Jamile Shammo MD - Rush University
  • Brady Stein MD - Northwestern

Kansas

Maryland

Massachusetts

Recommended Articles

Michigan

Minnesota

Missouri

New Jersey

New York

North Carolina

  • Lindsay Rein MD - Duke Health
  • Harry Erba MD
  • Brandi Reeves MD – UNC Hospital
  • Dimitry Berenzon MD – Wake Forrest Baptist Health

Ohio

Aaron T Gerds MD - The Cleveland Clinic Taussig Cancer Center Sarcoma Page (Cleveland, Ohio)

Oregon

Pennsylvania

South Carolina

  • Suzanne Fanning MD – GHS Cancer Institute

Tennessee

Texas

Utah

  • Michael Deininger MD – Huntsman Cancer Institute
  • Josef Prchal MD
  • Tswant Tashi MD

Virginia

  • Firas El Chaer MD – UVA, Emily Couric Clinical Cancer Center

Washington

Wisconsin

Who Should Get A Second Opinion?